89 results
6-K
EX-99.2
GNFT
Genfit
15 Apr 24
Current report (foreign)
4:10pm
to the Board of Directors to issue ordinary shares of the Company and/or securities giving access to the share capital of the Company, without … ’ preferential subscription rights, ordinary shares of the Company and/or securities giving access to the share capital of the Company, within the framework
6-K
EX-99.1
GNFT
Genfit
4 Apr 24
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
4:45pm
and market access expenses
Reorganization and restructuring expenses
Other operating income (expenses)
Operating income (loss)
Financial income … , general and administrative expenses, marketing and market access expenses, reorganization and restructuring expenses, and other operating expenses
6-K
EX-99.1
f85 ause9f
16 Nov 23
GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
4:10pm
6-K
EX-99.1
8qk06kg499p8q1bhmx
13 Nov 23
Current report (foreign)
4:30pm
6-K
EX-99.1
nn1t6ijgcbkd
6 Nov 23
GENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023
7:00am
6-K
EX-99.1
jojxc
26 Sep 23
GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
4:10pm
6-K
EX-99.1
35c 5klkke7
20 Sep 23
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
4:51pm
6-K
EX-99.1
ub1tbd4givv
20 Sep 23
Current report (foreign)
4:44pm
6-K
EX-99.1
rszs5h1zd4cd82 1d
5 Sep 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm
6-K
EX-99.2
pq02g2b7lq6peijpowy
19 Apr 23
Current report (foreign)
4:10pm
F-3
b4o6si2 at
18 Apr 23
Shelf registration (foreign)
2:33pm
6-K
EX-99.1
qgywo 3sowdj7v
14 Apr 23
GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update
7:00am